Brief: Maat Pharma Q1 Revenue At 300,000 Euros
May 5 (Reuters) - Maat Pharma SA MAAT.PA :
* Q1 REVENUE 300,000 EUR
* REVENUES OF EUR 0.3 MILLION IN Q1 2022
* AS OF MARCH 31, 2022, CASH AND CASH EQUIVALENTS OF
POSITIONS
WERE EUR 41.1 MILLION
Source text for Eikon: ID:nBw2XKNzga
Further company coverage: MAAT.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Maat Pharma SA
See all newsBrief: MaaT Pharma Says FDA Indicates No Additional Nonclinical Studies Required For MaaT034 Safety
France's MaaT Pharma H1 operating loss widens on higher R&D costs
Brief: MaaT Pharma SA Receives 'Negative Trend' Opinion For Upcoming June CHMP Vote For MaaT013 (Xervyteg)
France's MaaT Pharma 2025 revenue rises 40.7% but misses expectations
Brief: MaaT Pharma Says Xervyteg Under EMA Review, Decision Expected In H2 2026